News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
The Globe and Mail Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
U.S. Physical Therapy, Inc. has appointed Nchacha Etta as its new Executive Vice President and Chief Financial Officer, effective September 1, 2026. Etta brings extensive experience from previous CFO roles at Omnicell, Inc. and Essilor of America, Inc., as well as senior finance positions …
Bank of America Corp DE increased its stake in U.S. Physical Therapy, Inc. by 10.9% in the first quarter, now holding 554,621 shares valued at $41.6 million. Despite a revenue increase of 8.5% year-over-year, the company missed adjusted earnings expectations. Analysts maintain a "Moderate …
Kayne Anderson Rudnick Investment Management, LLC has filed an amended Schedule 13G, disclosing a beneficial ownership of 846,674 shares in US Physical Therapy Inc (USPH), which represents 5.6% of the company's common stock as of June 30, 2026. The firm holds both sole and …
This article provides an AI-generated analysis of U.s. Physical Therapy Inc. (NASDAQ: USPH), highlighting strong near and mid-term sentiment despite a weak long-term outlook. It identifies no resistance levels above the current price, suggesting compelling upside potential, and offers institutional trading strategies tailored to …
Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 10:30 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer - Christopher ReadingPresident and Chief Operating Officer, East - Eric WilliamsInterim Chief Financial Officer and Senior Vice President of Finance and Accounting - …
Morgan Stanley has reduced its beneficial ownership in U.S. Physical Therapy, Inc. (USPH) to 3.9% of common stock, filing an amended ownership report (SCHEDULE 13G/A). This new stake, totaling 596,683 shares, is below the 5% reporting threshold, indicating Morgan Stanley is no longer a …
U.S. Physical Therapy, Inc. (NYSE:USPH) has received a consensus "Moderate Buy" rating from seven brokerages, with an average 12-month price target of $97.50 against its current price of $79.89. The company's latest quarterly results showed an 8.5% year-over-year revenue increase to $214.06 million, though …
Barrington Research has increased its target price for US PHYSICAL THERAPY INC (USPH.N) to $98, up from the previous $90. This adjustment reflects the analyst's updated outlook on the company's valuation. The report was published by Reuters on August 10, 2026.
Barrington Research has maintained an "Outperform" rating for US Physical Therapy Inc (USPH) and raised its price target from $90.00 to $98.00. GuruFocus assesses USPH as 26.4% undervalued with a GF Value of $108.77, despite its current price of $80.05. The company exhibits strong …
Royal Bank of Canada significantly increased its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 22% in the first quarter, now holding 133,777 shares valued at $10.03 million. Despite reporting an 8.5% year-over-year revenue increase, the company missed EPS estimates but declared a quarterly …
U.S. Physical Therapy reported increased second-quarter revenue of US$214.06 million but a decline in net income to US$9.90 million, alongside a declared quarterly dividend of US$0.46 per share. This combination of higher sales and lower earnings per share suggests growing cost or reimbursement pressures, …
Renaissance Technologies LLC increased its holdings in U.S. Physical Therapy (NYSE:USPH) by 23.4% during the first quarter, now owning 76,956 shares valued at $5.8 million. Other institutional investors also significantly expanded their positions in the company. Despite missing analyst EPS estimates, U.S. Physical Therapy …
US Physical Therapy Inc (USPH) reported a record second quarter for 2026, with visits per clinic up significantly and strong revenue growth in both physical therapy and injury prevention segments. The company raised its full-year 2025 adjusted EBITDA guidance, reflecting a positive outlook despite …
U.S. Physical Therapy (USPH) reported mixed Q2 2026 results with increased revenue but lower net income and EPS, alongside affirming a $0.46 quarterly dividend. Despite a recent 31.71% share price surge over 90 days, the stock's year-to-date performance is slightly down, and its 3-year …
This press release details USPH's second quarter 2026 financial results, which include revenues of $55.0 million and adjusted EBITDA of $9.0 million. The company also reaffirmed its full-year 2026 guidance, projecting revenues between $215.0 million and $225.0 million and adjusted EBITDA between $37.0 million …
U.S. Physical Therapy, Inc. (USPH) announced its Q2 revenue reached $214.1 million, surpassing FactSet's estimated $211.4 million. The company operates 795 outpatient physical therapy clinics and provides industrial injury prevention services across 45 states. This earnings flash follows several recent activities, including a majority …
US Physical Therapy (USPH) is set to release its second-quarter results, with investors keenly watching its hospital partnership strategy's impact on profitability after a disappointing first quarter. Analysts are cautiously optimistic, expecting improved earnings and revenue, but concerns remain regarding execution on alliances, margin …
Copeland Capital Management, LLC has reported a 5.53% ownership stake in U.S. Physical Therapy (USPH), holding 841,544 shares of common stock. This disclosure was made in an amended Schedule 13G/A filing, indicating that the securities were acquired for investment purposes rather than to influence …
U.S. Physical Therapy (USPH) is scheduled to report its Q2 earnings tomorrow, August 4, 2026, after the market close. Analysts expect revenue growth of 6.4% year-on-year, a slowdown from the previous year's 18% increase. The company has a history of rarely missing Wall Street's …
U.S. Physical Therapy (USPH) stock appears overvalued based on its Price-to-Sales (P/S) ratio of 1.5x, which is higher than the implied fair P/S of 0.7x. Despite a 15.8% increase over the past year, investors holding the stock for three years have experienced a 29.3% …
This article provides an AI-driven analysis of U.s. Physical Therapy Inc. (NASDAQ: USPH), highlighting strong near and mid-term sentiment but a weak long-term outlook. It presents three institutional trading strategies (Position, Momentum Breakout, Risk Hedging) with specific entry, target, and stop-loss levels, and a …
This article examines potential bearish signals for U.S. Physical Therapy due to recent insider stock disposals. It analyzes the company's insider transactions, overall financial health, and market performance to assess the implications of these sales. The piece aims to provide insight into whether insider …
As investor enthusiasm for AI spending cools, this article highlights three defensive, non-tech stocks: Australian Clinical Labs (ASX:ACL), Employers Holdings (NYSE:EIG), and U.S. Physical Therapy (NYSE:USPH). These companies operate in healthcare and insurance, offering stability and different growth drivers compared to tech-heavy portfolios. The …
US Physical Therapy Inc (USPH) has a current valuation score of 5.34, placing it 68th out of 75 in the Healthcare Providers & Services industry. Its P/E ratio stands at 157.06, which is identical to its recent high and significantly above its recent low. …
This article provides a stock forecast and price targets for US Physical Therapy Inc (USPH), including analyst ratings and historical data. It details the company's financial overview, such as market capitalization, enterprise value, PE and PB ratios, and its GF Score. The main content …
Search by ticker symbol or company name and select a result to open its chart.